Overview

A Study of BMS-936558 With SBRT After Induction Chemotherapy in Cholangiocarcinoma

Status:
Recruiting

Trial end date:
2024-11-15

Target enrollment:

Participant gender:

Summary

This is an Open-label, single-arm, multicenter Phase II pilot study to assess the efficacy and safety of BMS-936558 with stereotactic ablative radiation therapy after induction chemotherapy in cholangiocarcinoma.

Phase:

Phase 2

Details

Lead Sponsor:

American University of Beirut Medical Center

Collaborator:

Bristol-Myers Squibb

Treatments:

Nivolumab